October 08, 2020 03:36 PM Eastern Daylight Time
BUSINESS WIRE
Riassunto: Takeda e Arrowhead collaborano allo sviluppo e alla commercializzazione di ARO-AAT per la malattia epatica correlata ad alfa-1-antitripsina
Tweet
View Full Size
Download
Full Size
JPEG
,
2183
x
780
,
175.0 KB
Small
JPEG
,
480
x
172
,
33.2 KB
Preview
JPEG
,
144
x
51
,
7.8 KB
Thumbnail
JPEG
,
120
x
43
,
6.4 KB
Smart Multimedia Gallery
View and Share Logo
Download Small
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Riassunto: Takeda e Arrowhead collaborano allo ...